PPA litigation
This article was originally published in The Tan Sheet
Executive Summary
Plaintiffs seeking class certification of economic injury claims "neither adequately demonstrated the predominance of common issues of law, nor provided the court" with a suitable trial plan, Seattle federal Judge Barbara Jacobs Rothstein says in Sept. 4 order denying class certification. Members of proposed class had sought refunds for PPA product purchases, disgorgement of company profits and creation of a fund supporting research, education and notification (1"The Tan Sheet" March 5, 2001, p. 3). The court denied class certification of PPA personal injury claims in June...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.